- Play for free
- Guide
-
Quick Nav
- Learn to Play
- Contractors
- Create Contractor
- Graveyard
- Gifts
- Create Gift
- Stock Gifts
- Community
-
Discord Server
- Looking for Game
- Find a Playgroup
- Hall of Fame
- Website
-
Get Early Access
- Buy Merchandise
- News and Updates
Richard Stroquer's Journal
(0-3) Hello Vietnam!
Downtime
Post Op #1: M.A.S.H
The harbinger was kind enough to drop me off at some U.S. military hospital in Thailand—burned-out helipad, buzzing fluorescents, the works. I don’t remember the landing. I do remember the pain kicking back in the second they pulled my makeshift oxygen rig off. Screaming wasn’t really an option with one lung full of blood and the other working overtime.
The surgeon looked at me like I was some kind of lunatic when I told him how I’d kept myself breathing. I asked if I could keep the rock fragments they pulled out—he said no. Bureaucracy.
They shoved a chest tube in, stitched me up, and pumped me full of enough drugs to make the walls breathe. I woke up handcuffed to the bed—standard protocol, apparently, when you’re dropped off by an unmarked helicopter with no passport, no ID, and a duffle bag full of explosives residue.
I told them I was CIA. They believed me.
Gen-Wyld: Beyond Natural
On March 14, 2018, a little-known company named Gen-Wyld announced FDA approval for a groundbreaking procedure to enhance a patient’s primary and secondary sexual characteristics using gene therapy. The company was an overnight success.
Shortly thereafter, they introduced a suite of gene-altering body modification procedures that allowed patients to make dramatic aesthetic changes to their bodies by gene-splicing “non-human” anatomy. Those daring (and wealthy) enough can now add cuttlefish pigmentation to their skin, sport a pair of fox ears, and even add a functional tail. While rare, these so-called “modders” draw plenty of hate from conservative communities.
Thanks to their revolutionary procedures, Gen-Wyld is now a household name. Norman Carlson, Gen-Wyld’s chief evangelist, recently announced the company is in the trial phase for a groundbreaking treatment for diabetes.
Yet despite their success, a shroud of secrecy surrounds Gen-Wyld. Their no-patent policy obscures the secrets of their procedures from the public eye. Financial experts claim that Gen-Wyld is run less like a traditional business and more like an NGO with some specific, unknown objective.
Some claim that they will not stop until humanity has been reduced to monstrous slaves and that Gen-Wyld’s board of directors will install themselves as inhuman overlords of the new world order.
However, until the true secrets behind Gen-Wyld are discovered, the genetic biotech firm will continue to grow, develop, and progress its grand designs.